Pharmaceuticals

Tue, 08/24/2010 - 13:37

Kangmei Pharma to raise $514 mln to expand TCM operations

Shanghai. August 24. INTERFAX-CHINA - Guangdong Province-based Kangmei Pharmaceutical Co. Ltd. plans a rights issue to raise a maximum of RMB 3.5 billion ($514.85 million) to fund expansion of its traditional Chinese medicine (TCM) business, the company announced Aug. 24.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW